<DOC>
	<DOCNO>NCT02065167</DOCNO>
	<brief_summary>The purpose ass safety feasibility cellular therapy derive bone marrow , help bone heal patient avascular necrosis hip .</brief_summary>
	<brief_title>Evaluation Mesenchymal Stem Cells Treat Avascular Necrosis Hip</brief_title>
	<detailed_description>To assess safety feasibility situ single injection high dose autologous bone marrow-derived , vitro expand Mesenchymal stem cell , contribution resolution early stage avascular osteonecrosis femoral head .</detailed_description>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Femur Head Necrosis</mesh_term>
	<criteria>Age 18 65 , sex Early avascular necrosis fem oral head ( MRI diagnosis ) : Ficat Arlet 0 , 1 , 2 ( Steinberg stag 0 , I , IIA , IIB , IIC ) Sym ptom atic osteonecrosis le 6 month evolution Able provide inform consent , sign inform consent Medical health care coverage Pregnancy , breast feeding woman woman childbearing age practice adequate birth control . Participation another therapeutic trial previous 3 onths Stages 3 ore ( Ficat Arlet ) III ore ( Steinberg ) severe fem oral head osteonecrosis , primarily base diagnosis im age ( XRays , MRI ) . Flattening collapse fem oral head ( Steinberg stage IV ) articular cartilage collapse time core decompression surgery . Septic arthritis . Stress fracture . Nonosteonecrosis metabolic bone disease ( particularly Paget 's disease bone , osteogenesis imperfecta , primary hyperparathyroidism , fibrous dysplasia monostotic , polyostotic McCuneAlbright syndrome ] osteopetrosis ) . Any active bisphosphonate treatment history intravenous ( IV ) treatment . History prior concurrent diagnosis HIV , HepatitisB HepatitisCinfection Active hepatitis B hepatitis C infection time screen . Known allergy product involve production process MSC . History neoplasia current neoplasia organ . Corticoid immunosuppressive therapy one week two month prior study inclusion Patients require continuous , systemic , high dose corticosteroid therapy ( 7.5 g/day ) within 6 month surgery . Patients active treatment cancer blood dyscrasia , receive chemotherapy , radiotherapy immunotherapy past 2 year . History regular alcohol consumption exceed 2 drinks/day within 6 month screen and/or history illicit drug use . Serum AST ( SGO T ) /ALT ( SGPT ) &gt; 2.5 X ( institutional standard range ) . MRIincompatible internal device ( pacemaker , aneurysm clip , etc ) . Body mass index ( BMI ) 40 kg/m Â² great . Patients unable tolerate general anesthesia define American Society Anesthesiologists ( ASA ) criteria &gt; 2 . Insulin dependent diabetes Patients poorly control diabetes mellitus ( HbA1C &gt; 8 % ) , peripheral neuropathy , know concomitant vascular problem . Patients receive treatment hematopoietic growth factor antivasculogenesis antiangiogenesis treatment . Traumatic osteonecrosis . Adult care guardian ( Subject legally protect ) Im possibility meet appointment clinical follow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>avascular necrosis femoral head</keyword>
	<keyword>cell therapy</keyword>
	<keyword>Mesenchymal stem cell</keyword>
</DOC>